难治性急性白血病研究现状与进展

难治性急性白血病治疗反应差,诱导缓解率低,复发率高,生存期短,因而是白血病治疗中的难题。本文从难治性急性白血病诊断标准与免疫学、细胞遗传学及分子生物学特征,多药耐药与难治性白血病,难治性急性白血病治疗现状以及治疗展望五大方面阐述了难治性急性白血病研究现状与进展。基础与初步临床研究显示中药配合化疗能够提高难治性急性白血病围化疗期临床缓解率。认为中药在提高难治性白血病临床疗效方面具有潜在临床应用前景和开发的商业价值,值得进行深入研究。     

骨折电流疗法的改良

目的:针对电流治疗骨折等疾病时存在的问题,提出相应的改进方法。方法:分析以往使用电流对骨折等疾病进行治疗时存在的电化学副作用、创口易于感染、重复施术不便等问题,提出相应的诸如使用溶液导电、隔离电解物、使电极与创口闭合生长等改进方法;并提出将电流治疗与药物治疗相结合的骨科疾病电流疗法改良方案。结果:将电流与药物相结合治疗骨折等疾病是很有可行性的治疗方法,本法不仅克服了已往疗法存在的一些问题,还为骨伤药物直接进入病患部位提供了有效的平台,使骨折、骨不连等疾病能够快速愈合。今后应加强研究骨折愈合各阶段所需的直接注射药物及其配比。完善电流—药物复合电极使用方法,以便与本法尽快进入临床实践。结论:将电流与药物相结合治疗骨折等疾病是很有可行性的治疗方法。     

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population

The inclusion of a genetic risk score (GRS) can modify the risk prediction of coronary artery disease (CAD), providing an advantage over the use of traditional models. The predictive value of the genetic information on the recurrence of major adverse cardiovascular events (MACE) remains controversial. A total of 33 genetic variants previously associated with CAD were genotyped in 1587 CAD patients from the GENEMACOR study. Of these, 18 variants presented an hazard ratio >1, so they were selected to construct a weighted GRS (wGRS). MACE discrimination and reclassification were evaluated by C-Statistic, Net Reclassification Index and Integrated Discrimination Improvement methodologies. After the addition of wGRS to traditional predictors, the C-index increased from 0.566 to 0.572 (p=0.0003). Subsequently, adding wGRS to traditional plus clinical risk factors, this model slightly improved from 0.620 to 0.622 but with statistical significance (p=0.004). NRI showed that 17.9% of the cohort was better reclassified when the primary model was associated with wGRS. The Kaplan-Meier estimator showed that, at 15-year follow-up, the group with a higher number of risk alleles had a significantly higher MACE occurrence (p=0.011). In CAD patients, wGRS improved MACE risk prediction, discrimination and reclassification over the conventional factors, providing better cost-effective therapeutic strategies.     

传统中药白芍原植物分类鉴定及根形态解剖研究

对我国主产地的白芍(Radix Paeonia alba)原植物10个居群进行调查及标本采集,植物鉴定结果为：川白芍原植物粉红花居群为原变种芍药Paeonia lactiflora Pall,白花居群为芍药变种毛果芍药P.lactiflora var.trichocarpa(Bunge)Stern;毫白芍原植物线条居群和蒲棒居群均为芍药;杭白芍原植物红花、白花、粉红花居群均为毛果芍药;陕西韩城、江苏东海、山东荷泽白芍均为芍药,各居群在花色及形态上有明显而稳定的变异。根横切面解剖结构显示,按木质部的排列方式可将白芍原植物10个居群分为两大类：第一类为有呈两个不相连的扇形中央导管群,并且有狭长、具分枝的从形成层到根中央部分连续排列的木质部,基本上是原植物芍药的植物特征,其中毫白芍线条居群兼有毛果芍药和芍药的特征;第二类为具有不明显的根中央扇形导管束,导管束呈环状围绕中央排列,并且有粗短不分枝的靠近形成层处成群的导管,与原植物毛果芍药的特征基本一致,其中杭白芍红花居群与川白芍白花居群根中央导管群呈现较明显的2个分离扇形排列,类似芍药。白芍原植物的种分类定位与花色无密切关联,但由于性状的稳定,可以考虑作为变种或变型定位。     

储藏中药材孳生粉螨的调查

采用清水漂浮法和塔氏电热集螨器分离法,共分离中药材样品129种,1290份,从中分离出粉螨44种,隶属7科25属。得出结论:中药材粉螨的污染严重,应加强对中药材螨类的防治,以保护中药材及预防人体螨病。     

Genetic diversity and biogeography of the traditional Chinese medicine, Gardenia jasminoides, based on AFLP markers

Gardenia jasminoides Ellis is used in traditional Chinese medicine (TCM) in China. Levels of genetic variation and patterns of population structure within and among eight wild or cultivated populations of G. jasminoides Ellis in China were investigated using amplified fragment length polymorphism (AFLP) markers. Of the 11 primers screened, four produced highly reproducible AFLP bands. Using these primers, 244 discernible DNA fragments were generated with 165 bands (67.6%), were polymorphic, indicating considerable genetic variation at the species level. In contrast, there were relatively low levels of polymorphism at the population level with the percentage of polymorphic bands (PPB) ranging from 36.89% to 59.43%. Genetic diversity within populations ranged from 0.2086 to 0.3108, averaging 0.2392 at the species level. A high level of genetic differentiation among populations was detected based on Nei's genetic diversity analysis (76.59%), Shannon's index analysis (64.8%) and AMOVA analysis (72.75%). No significant statistical differences (analysis of molecular variance [AMOVA], p = 0.0639) in AFLP variation were found between regions. However, the variance among populations and within populations differed significantly (p < 0.001). An indirect estimate of historical levels of gene flow (N_m = 1.7448) was consistent with the high mean genetic identity (mean I = 0.9263) found among populations. There is an association between geographic and genetic distances between populations. Presently gene change exists between populations.     

中药治疗非酒精性脂肪肝病研究进展

非酒精性脂肪肝病(NAFLD)指排除酒精和其他明确的损肝因素所致的肝细胞内脂肪过度沉积为主要特征的临床病理综合征。目前,该病的发病机制错综复杂,西药尚缺乏治该病的特效药,主要是运用调节血脂的药物作为辅助治疗。中药在治疗NAFLD方面具有安全、毒副作用低等优势,近年来对中药治疗NAFLD的研究也越来越多。在梳理了国内外治疗NAFLD成果的基础上,本文分别从单味中药、复方中药等方面详细阐述中药治疗NAFLD的现状,旨在为NAFLD的临床治疗提供参考。     

中心静脉导管引流对单孔胸腔镜肺癌根治术患者术后胸腔引流的应用分析

目的:探讨中心静脉导管引流对单孔胸腔镜肺癌根治术患者术后胸腔引流的应用效果。方法:回顾性选取2019年1月至2019年12月期间我院收治的行单孔胸腔镜肺癌根治术患者80例的临床资料,根据引流方式的不同分为A组(n=40,传统引流)和B组(n=40,中心静脉导管引流),对比两组患者临床指标、生活质量、炎性因子及并发症发生情况。结果:B组引流操作时间、术后住院时间短于A组(P0.05)。两组术后3个月生活质量简表(SF-36)各维度评分均较术前升高,且B组高于A组(P0.05)。两组术前、术后3d、术后7d白介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)呈先升高后下降趋势,且术后3d、术后7d B组以上指标低于A组(P0.05)。两组术后并发症发生率比较无差异(P0.05)。结论:与传统引流相比,单孔胸腔镜肺癌根治术患者术后采用中心静脉导管引流,效果显著,可减少炎性刺激,安全可靠,有效改善患者术后生活质量。     

西双版纳传统利用的野生药食两用植物

2010年3月至2011年7月对西双版纳少数民族传统利用的药食两用植物进行民族植物学调查,通过访谈和野外调查工作,收集并记录了关于当地社区传统利用药食两用植物的传统知识以及其他相关信息,并选择了其中20种植物进行抗菌活性的筛选。共调查统计了43科95种西双版纳传统利用的药食两用植物,从分类学角度来看,以茄科（6种）和唇形科（6种）最多,其中草本植物占了最大比例,为49．5％。对其中20种植物的抗菌活性筛选结果显示,只有马蓝（Baphicacanthus cusia）和旋花茄（Sola-humspirale）对金黄色葡萄球菌有抑菌活性。从调查中可以看出：药食两用植物的利用在当地人的日常生活中仍占有相当重要的分量。但随着近年来经济快速发展导致的传统知识的急剧流失和森林的大面积砍伐,很多植物已经逐渐从人们的生活中淡出．如何保护这些传统知识并使其能够可持续发展下去是一个值得思考的问题。